Bear Market Rally Spurs Biotech Stocks: A Primer on Tariffs…Update-3…Pivot Day Confirmed

Update-3 ...ABBVIE (ABBV) beat with adj. EPS 2.46 earnings and revenues of $13.343B  an increase of 4%,but tariff issues lurking., but I$10M investments will be made in U.S. Strong sales $6.264B of new immunology drugs Rinvoq and Skirizi an increase of 16.6%.  EPS guidance raised too...

Is it a Good Time to Trade Small Cap Biotech Stocks?– 3 Steps to Consider…Update-3 …How do NIH cutbacks affect ongoing clinical trials?

UPDATE 4/15/25: Nice Rally in SMID BiOTECH on Monday then faded. UPDATE tomorrow with UNH Congress needs to do their job and prioritize cancer research funding especially for clinical trials. Update-3 4/13...We will summarize market performance for healthcare and biotech on our next update: XLV...

Hell Week in March 2025: Detoxing with Tariffs until April 2? Update-4…No Liberation from new BEAR today as of 4/4 11a

Update-4 4/6/25 ...Signposts at end of Hell Week, here are values: XLV at 135.28...down 6.39% week ,1.66% YTD, IBB at $117.16 down  10.08% week, 11.38% YTD, XBI  at $73.66 down 12.73% % week, 18.21% YTD. DOW down 9.9% YTD, NASDAQ 100 down 17.2% YTD, S&P 500 down 13.7% YTD. ===========...

Pin It on Pinterest